Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.63 USD | +2.67% | +1.12% | -0.08% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.08% | 2.49B | |
-1.78% | 41.71B | |
+47.70% | 41.56B | |
+4.01% | 39.74B | |
-15.14% | 25.61B | |
+3.16% | 24.26B | |
-24.08% | 18.55B | |
-2.67% | 11.93B | |
+24.76% | 11.93B | |
+7.01% | 10.91B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- HC Wainwright Adjusts Celldex Therapeutics' Price Target to $73 from $60, Keeps Buy Rating